Nivestym (filgrastim-aafi) Injection, 480 mcg/0.8 mL Prefilled Syringe, Each
Nivestym is a biosimilar to Neupogen (filgrastim), a leukocyte growth factor used to reduce the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy. This presentation is a single-dose prefilled syringe containing 480 mcg of filgrastim-aafi in 0.8 mL of solution, administered by subcutaneous or intravenous injection.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Nivestym is a biosimilar to Neupogen (filgrastim), a leukocyte growth factor used to reduce the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy. This presentation is a single-dose prefilled syringe containing 480 mcg of filgrastim-aafi in 0.8 mL of solution, administered by subcutaneous or intravenous injection.
1 vendor
